Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 108, Issue 10, Pages djw122
Publisher
Oxford University Press (OUP)
Online
2016-06-01
DOI
10.1093/jnci/djw122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
- (2015) Masaya Kai et al. BREAST CANCER RESEARCH AND TREATMENT
- Hitting the brakes: targeting microtubule motors in cancer
- (2015) Gayathri Chandrasekaran et al. BRITISH JOURNAL OF CANCER
- SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
- (2015) S.-W. Tang et al. CLINICAL CANCER RESEARCH
- Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?
- (2015) M. C. Pietanza et al. CLINICAL CANCER RESEARCH
- Mitosis, microtubule dynamics and the evolution of kinesins
- (2015) Juan Jesus Vicente et al. EXPERIMENTAL CELL RESEARCH
- NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas
- (2015) Lydia Meder et al. INTERNATIONAL JOURNAL OF CANCER
- Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma
- (2015) Yuki Matsumura et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial
- (2015) Ariel Lopez-Chavez et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- A comprehensive transcriptional portrait of human cancer cell lines
- (2014) Christiaan Klijn et al. NATURE BIOTECHNOLOGY
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
- (2014) A. Augustyn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmaco-miR: linking microRNAs and drug effects
- (2013) J. L. Rukov et al. BRIEFINGS IN BIOINFORMATICS
- Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216
- (2013) Marlena Walls et al. CLINICAL CANCER RESEARCH
- Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer
- (2013) R. J. Cardnell et al. CLINICAL CANCER RESEARCH
- ERK Phosphorylation Is Predictive of Resistance to IGF-1R Inhibition in Small Cell Lung Cancer
- (2013) R. L. Zinn et al. MOLECULAR CANCER THERAPEUTICS
- Genomic Deregulation of the E2F/Rb Pathway Leads to Activation of the Oncogene EZH2 in Small Cell Lung Cancer
- (2013) Bradley P. Coe et al. PLoS One
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- microRNA regulation of cell viability and drug sensitivity in lung cancer
- (2012) Liqin Du et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- A framework for identification of actionable cancer genome dependencies in small cell lung cancer
- (2012) M. L. Sos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets
- (2011) D. S. Castro et al. GENES & DEVELOPMENT
- A phase I trial of MK-0731, a Kinesin Spindle Protein (KSP) inhibitor, in patients with solid tumors
- (2011) Kyle Holen et al. INVESTIGATIONAL NEW DRUGS
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Global microRNA Analysis of the NCI-60 Cancer Cell Panel
- (2011) R. Sokilde et al. MOLECULAR CANCER THERAPEUTICS
- Novel strategies for the treatment of small-cell lung carcinoma
- (2011) William N. William et al. Nature Reviews Clinical Oncology
- MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer
- (2011) Jih-Hsiang Lee et al. PLoS One
- The molecular pathogenesis of small cell lung cancer
- (2010) Sandra P. D’Angelo et al. CANCER BIOLOGY & THERAPY
- Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer
- (2010) A. Tarhini et al. CLINICAL CANCER RESEARCH
- Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer
- (2010) Andrzej Badzio et al. Journal of Thoracic Oncology
- mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities
- (2010) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Small Cell Lung Cancer: Past, Present, and Future
- (2010) Estelamari Rodriguez et al. Current Oncology Reports
- Different forms of cell death induced by putative BCL2 inhibitors
- (2009) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
- (2009) M. Marinov et al. CLINICAL CANCER RESEARCH
- A small-cell lung cancer genome with complex signatures of tobacco exposure
- (2009) Erin D. Pleasance et al. NATURE
- Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
- (2008) C. L. Hann et al. CANCER RESEARCH
- Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
- (2008) A. R. Shoemaker et al. CLINICAL CANCER RESEARCH
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
- Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt
- (2007) Juddi Yeh et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now